The Journal of the Pakistan Medical Association
Click here to listen to this article Share via GLP-1 medications have undoubtedly reshaped the conversation around weight loss almost overnight
Serious but rare risks include hypoglycemia (low blood sugar), acute pancreatitis (severe, persistent abdominal pain often with vomiting), acute gallbladder disease (sudden right-upper abdominal pain that may radiate to the shoulder), non-arteritic anterior ischemic optic neuropathy (sudden, potentially permanent vision loss), mood changes, and severe allergic reactions with breathing difficulty or swelling of the lips, tongue, or throat
The researchers assessed kidney oxygenation (R2*) using blood oxygenation leveldependent MRI, and they assessed mean global kidney perfusion (GKP), renal artery resistive index (RARI), and cortical and medullary estimates of fibrosis (diffusion-weighted imaging for the apparent diffusion coefficient [ADC]) with phase-contrast MRI-measured arterial flow
Hypoglycaemia Incidence of any hypoglycaemia (defined as plasma glucose 3.9 mmol/l) with tirzepatide did not differ vs placebo (ESM Fig
Wie GLP-1 Wirkt Es handelt sich um ein Hormon, das als Reaktion auf die Nahrungsaufnahme, insbesondere aus dem Darm, freigesetzt wird